Track the 헬릭스미스 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 헬릭스미스 has published 45 insider filings. Market capitalisation: €219.4bn. The latest transaction was reported on 11 March 2026 (Other). Among the most active insiders: 헬릭스미스. All data is openly available.
45
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
10 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 17,285 of 25,596 companies
40.4
score / 100
Value
27
Quality
53
FCF yld-4.2%
Earn yld-0.3%
EV/EBITDA·
ROE·
Gross mgn38%
Net mgn-17%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.